Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules

Histopathology

Volumn 41, Issue 3, 2002, Pages 236-243

  Beesley, M F ^a   McLaren, Kathryn M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cytokeratin 19; Follicular adenoma; Follicular carcinoma; Galectin 3; Immunohistochemistry; Papillary carcinoma; Thyroid

Indexed keywords

CYTOKERATIN 19; GALECTIN 3;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; NODULAR GOITER; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID CARCINOMA; THYROID NODULE;

DIAGNOSIS, DIFFERENTIAL; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; RETROSPECTIVE STUDIES; THYROID NODULE;

EID: 0036042779     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01442.x     Document Type: Article

References (40)

1. Endogenous lectins from cultured cells: Nuclear localisation of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts
2. Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion
3. Interaction between galectin-3 and mac-2 binding protein mediates cell-cell adhesion
4. S-type mammalian lectins in allergic inflammation
5. Expression of T-cell growth and apoptosis
6. Induction of tumourigenicity by galectin-3 in a non-tumourigenic human breast carcinoma cell line
7. Decreased expression of galectin-3 is associated with progression of human breast cancer
8. Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas
9. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon
10. Observer variation in histologic classification of thyroid cancer
11. Fine needle aspiration biopsy in the management of thyroid nodules
12. High-molecular weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumours
13. Differential expression of galectin-1 and galectin-3 in thyroid tumours: Potential diagnostic implications
14. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules
15. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules
16. Distribution of Leu-7 antigen (HNK-1) in thyroid tumours: Its usefulness as a diagnostic marker for follicular and papillary carcinomas
17. The immunohistochemical localization of S100 in the diagnosis of papillary carcinoma of the thyroid
18. Patterns of cytoskeletal proteins in human thyroid gland and thyroid carcinoma
19. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinoma and follicular thyroid adenoma
20. Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility
21. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications
22. Patterns of expression of intermediate cytokeratin filaments in the thyroid gland: An immunohistochemical study of simple and stratified epithelial-type cytokeratins
23. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma
24. Primary squamous cell carcinoma of the thyroid gland: An entity with aggressive clinical behaviour and distinctive cytokeratin expression profiles
25. Papillary carcinoma of the thyroid. A discussion of its several morphologic expressions with practical emphasis on the follicular variant
26. Epithelial tumour markers: Cytokeratins and tissue polypeptide antigen (TPA)
27. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue
28. Galectin-3 is a presurgical marker of human thyroid carcinomas
29. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms
30. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue
31. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation
32. Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: Possible relation to tumour progression
33. Galectins: Structure and function of a large family of animal lectins
34. Galectins. A family of animal lectins that decipher glycocodes
35. Purification of galectin-3 from ovine placenta: Developmentally regulated expression and immunological relevance
36. Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis
37. Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathway of trophoblasts
38. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
39. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3
40. Concentrations of galectin-3 in the sera of normal controls and cancer patients